RealTime Dynamix™: Bone and Mineral Metabolism US Q2 2018 Spotlight

RealTime Dynamix™: Bone and Mineral Metabolism US Q2 2018 Spotlight

hyperkalemia q1

Last month Spherix surveyed 201 US nephrologists about their management of secondary hyperparathyroidism, vitamin D insufficiency, and hyperphosphatemia in the dialysis and non-dialysis settings. See complimentary highlights from the Q2 2018 wave of RealTime Dynamix™: Bone and Mineral Metabolism US below.

Contact [email protected] for more information about the highlighted report or to see if your company already has access to the report series.

All company, brand or product names and logos in this document are trademarks of their respective holders.

2018-07-30T12:35:16+00:00